IL6 and gastric cancer: Trastuzumab treatment rendered resistance to itself, facilitated epithelial-to-mesenchymal transition and enhanced metastatic potential in gastric cancer cells through an IL6/STAT3/Jagged-1/Notch positive feedback loop [48].